2019 CYIR Finalized

14 2. The findings do not support the use of low-dose theophylline as adjunctive therapy to inhaled corticosteroids for the preven- tion of COPD exacerbations. 3. In secondary analysis, low-dose theophylline did reduce the number of severe COPD exacerbations requiring hospital admission but the most benefit being evident in a small (1%- 2%) subgroup of patients frequently hospitalized with COPD. 4. There were no significant differences in non-COPD hospi- tal admissions, episodes of pneumonia, FEV1, CAT score, mMRC dyspnea score, or mortality (COPD-related and overall) between the 2 groups 5. This study has several limitations, including more participants than anticipated (26%) ceased taking the study drug. OTHER ARTICLES OF INTEREST Treatment Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M, Bourne E, Ballal S, Darken P, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallelgroup, multicentre, phase 3 randomised controlled trial. Lancet Respir Med 2018; 6: 747-758. Walker PP, Pompilio PP, Zanaboni P, Bergmo TS, Prikk K, Malinovschi A, Montserrat JM, Middlemass J, Sonc S, Munaro G, Marusic D, Sepper R, Rosso R, Siriwardena AN, Janson C, Farre R, Calverley PMA, Dellaca RL. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial. Am J Respir Crit Care Med 2018; 198: 620-628. Martinez FJ, Rabe KF, Calverley PMA, Fabbri LM, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VKT, Siddiqui S, Reisner C, Zetterstrand S, Roman J, Purkayastha D, Bagul N, Rennard SI. Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials. Am J Respir Crit Care Med 2018; 198: 1268-1278. Mechanism Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, Chen V, FitzGerald JM, Nislow C, Leung JM, Man SFP, Sin DD. Sputum Microbiome is Associated with 1-Year Mortality Following COPD Hospitalizations. Am J Respir Crit Care Med. 2018 Oct 30. doi: 10.1164/ rccm.201806-1135OC. [Epub ahead of print] PubMed PMID: 30376356. Vasilescu DM, Martinez FJ, Marchetti N, Galbán CJ, Hatt C, Meldrum CA, Dass C, Tanabe N, Reddy RM, Lagstein A, Ross BD, Labaki WW, Murray S, Xia M, Curtis JL, Hackett TL, Kazerooni EA, Criner GJ, Hogg JC, Han MK. Non- Invasive Imaging Biomarker Identifies Small Airway Damage in Severe COPD. Am J Respir Crit Care Med. 2019 Feb 22. doi: 10.1164/rccm.201811-2083OC. [Epub ahead of print] PubMed PMID: 30794432. Review Labaki W, Lucas M. Kimmig LM, Mutlu GM, Han MK, Bhatt SP. Update in Chronic Obstructive Pulmonary Disease 2018. Am J Respir Crit Care Med. [Articles in press] Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD Science Committee Report 2019. Eur Respir J. 2019 Mar 7. pii: 1900164. doi: 10.1183/13993003.00164- 2019. [Epub ahead of print] Review. COPD

RkJQdWJsaXNoZXIy MTM1ODMw